Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ID › Mountain Home › NPI 1699013565
Hospital

ST Lukes Regional Medical Center

ST Lukes Regional Medical Center was paid $942K by Medicaid between Jan 2018 and Nov 2024, across 108 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.

33Billing provider infoST LUKES REGIONAL MEDICAL CENTER
MOUNTAIN HOME, ID 83647
33aNPI1699013565assigned 01/28/2013
33bProvider typeCritical Access Hospital
28Total paid$942K
24GClaims74,296
24DCodes billed108
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Critical Access Hospital providers in Idaho

Rank by total paid#5 of 20
Median peer was paid$348K
This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official FOWLER, KATHRYN controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201823,531$314K
201922,932$274K
202012,439$150K
20213,495$35K
20224,510$60K
20235,169$79K
2024incomplete2,220$29K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 1,311 1,125 $149K
74177 Computed tomography, abdomen and pelvis; with contrast material 10% 578 548 $96K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10.0% 1,103 941 $94K
80053 Comprehensive metabolic panel 5.9% 7,008 5,907 $55K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5.4% 8,739 7,132 $51K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.7% 738 574 $35K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3.4% 422 393 $32K
70450 Computed tomography, head or brain; without contrast material 2.3% 511 482 $22K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.1% 559 500 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.1% 559 500 $20K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.1% 1,221 965 $20K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.9% 142 114 $18K
96 more codes
84443 Thyroid stimulating hormone (TSH) 1.7% 1,215 $16K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.6% 230 $15K
81001 1.5% 4,441 $14K
84484 1.5% 1,908 $14K
36415 Collection of venous blood by venipuncture 1.5% 6,805 $14K
71046 Radiologic examination, chest; 2 views 1.4% 1,073 $13K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.4% 727 $13K
83690 1.3% 1,869 $13K
87086 Culture, bacterial; quantitative colony count, urine 1.3% 1,812 $12K
J7050 Infusion, normal saline solution, 250 cc 1.2% 2,650 $11K
J7030 Infusion, normal saline solution , 1000 cc 1.1% 1,930 $10K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 143 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 656 $9K
80048 Basic metabolic panel (calcium, ionized) <1% 1,351 $9K
71045 Radiologic examination, chest; single view <1% 1,323 $8K
84702 <1% 455 $7K
87081 <1% 942 $6K
87077 <1% 745 $6K
81025 <1% 856 $6K
80061 Lipid panel <1% 730 $6K
J7120 Ringers lactate infusion, up to 1000 cc <1% 998 $6K
82962 <1% 3,767 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 274 $6K
83605 <1% 545 $6K
76830 Ultrasound, transvaginal <1% 83 $5K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 874 $5K
84439 <1% 651 $5K
80306 <1% 281 $4K
83880 <1% 173 $4K
99213 Doctor's office visit, returning patient (routine) <1% 434 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 744 $4K
87186 <1% 427 $4K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 59 $3K
85379 <1% 288 $3K
87040 <1% 218 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 939 $3K
86140 <1% 370 $2K
84481 <1% 180 $2K
J2704 Injection, propofol, 10 mg <1% 86 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,049 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 51 $2K
85610 <1% 489 $2K
99214 Doctor's office visit, returning patient (more involved) <1% 342 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 44 $2K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 27 $2K
71275 Computed tomographic angiography, chest, with contrast material <1% 12 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 151 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 62 $2K
73630 <1% 111 $1K
86850 <1% 183 $1K
74018 <1% 69 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 515 $1K
73610 <1% 72 $1K
87420 <1% 79 $1K
72125 Computed tomography, cervical spine; without contrast material <1% 13 $1K
86901 <1% 306 $958.48
73564 <1% 36 $814.66
J2270 Injection, morphine sulfate, up to 10 mg <1% 290 $801.40
86900 <1% 247 $770.46
73110 <1% 40 $726.20
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 191 $716.73
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 17 $699.92
85652 <1% 133 $699.72
S3620 Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) <1% 13 $663.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 61 $641.34
86593 <1% 132 $587.98
36416 <1% 209 $579.65
86703 <1% 43 $578.73
J1170 Injection, hydromorphone, up to 4 mg <1% 46 $560.97
82728 <1% 50 $530.25
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 163 $500.83
84703 <1% 55 $483.65
82607 <1% 37 $476.36
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 44 $472.05
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 306 $458.30
87210 <1% 96 $447.90
83735 <1% 80 $402.19
96361 Intravenous infusion, hydration; each additional hour <1% 32 $402.18
J2550 Injection, promethazine hcl, up to 50 mg <1% 61 $262.07
87340 <1% 28 $252.54
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 14 $243.26
86803 <1% 13 $198.28
90715 <1% 13 $185.70
86762 <1% 13 $143.91
72100 <1% 12 $136.22
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 13 $128.59
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 158 $104.78
81002 <1% 44 $88.54
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 627 $70.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 13 $60.90
G0008 Administration of influenza virus vaccine <1% 54 $45.07
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 74 $37.50
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 667 $0.03
A9270 Non-covered item or service 0% 376 $0.00
80050 General health panel 0% 35 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 0% 42 $-7.43

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFOWLER, KATHRYN (SENIOR VP, CFO)
Parent organizationST LUKES HEALTH SYSTEM LTD
Same official

Other billing entities under FOWLER, KATHRYN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.